Profound Medical (PROF) Revenue & Revenue Breakdown
Profound Medical Revenue Highlights
Latest Revenue (Y)
$10.68M
Latest Revenue (Q)
$1.90M
Main Segment (Y)
Recurring - Non-Capital
Main Geography (Y)
UNITED STATES
Profound Medical Revenue by Period
Profound Medical Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $10.68M | 48.35% |
2023-12-31 | $7.20M | 7.75% |
2022-12-31 | $6.68M | -2.79% |
2021-12-31 | $6.87M | -5.90% |
2020-12-31 | $7.30M | 72.61% |
2019-12-31 | $4.23M | 121.48% |
2018-12-31 | $1.91M | -51.01% |
2017-12-31 | $3.90M | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | - |
Profound Medical generated $10.68M in revenue during NA 2024, up 48.35% compared to the previous quarter, and up 252.39% compared to the same period a year ago.
Profound Medical Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $1.90M | -7.90% |
2023-12-31 | $2.06M | 19.47% |
2023-09-30 | $1.73M | 7.87% |
2023-06-30 | $1.60M | -13.87% |
2023-03-31 | $1.86M | 47.97% |
2022-12-31 | $1.26M | -38.23% |
2022-09-30 | $2.04M | 0.49% |
2022-06-30 | $2.02M | 48.46% |
2022-03-31 | $1.36M | 36.67% |
2021-12-31 | $998.00K | -60.66% |
2021-09-30 | $2.54M | -3.43% |
2021-06-30 | $2.63M | 269.48% |
2021-03-31 | $711.00K | -75.05% |
2020-12-31 | $2.85M | 27.98% |
2020-09-30 | $2.23M | 114.00% |
2020-06-30 | $1.04M | -5.41% |
2020-03-31 | $1.10M | -49.25% |
2019-12-31 | $2.17M | 320.63% |
2019-09-30 | $515.35K | 17.84% |
2019-06-30 | $437.32K | -60.43% |
2019-03-31 | $1.11M | -9.34% |
2018-12-31 | $1.22M | 418.72% |
2018-09-30 | $235.03K | 44.89% |
2018-06-30 | $162.21K | -44.34% |
2018-03-31 | $291.41K | -80.18% |
2017-12-31 | $1.47M | 24.49% |
2017-09-30 | $1.18M | 60.51% |
2017-06-30 | $735.94K | 65.92% |
2017-03-31 | $443.56K | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-03-31 | - | - |
Profound Medical generated $1.90M in revenue during Q1 2024, up -7.90% compared to the previous quarter, and up 151.27% compared to the same period a year ago.
Profound Medical Revenue Breakdown
Profound Medical Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 | Dec 22 | Dec 21 |
---|---|---|---|
Capital Equipment | $2.44M | - | - |
Recurring - Non-Capital | $8.24M | - | - |
Recurring - non-capital | - | $4.68M | $3.29M |
Capital equipment | - | $2.00M | $3.15M |
Latest
Profound Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Recurring - Non-Capital (77.15%), and Capital Equipment (22.85%).
Profound Medical Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 24 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
CALIFORNIA | $2.44M | - | - | - | - |
DELAWARE | $891.00K | - | - | - | - |
UNITED STATES | $7.35M | - | - | - | - |
USA | - | $3.40M | $2.09M | - | - |
Canada | - | $1.49M | $1.72M | - | - |
Germany | - | $1.80M | $1.43M | - | - |
C | - | - | - | $4.76M | $3.00M |
D | - | - | - | $1.47M | $1.89M |
Latest
Profound Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (68.82%), CALIFORNIA (22.84%), and DELAWARE (8.34%).
Profound Medical Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ITGR | Integer | $1.72B | $746.27M |
LIVN | LivaNova | $1.25B | $318.11M |
NVRO | Nevro | $408.52M | $104.16M |
AORT | Artivion | $388.54M | $95.78M |
FNA | Paragon 28 | $256.18M | $61.02M |
KIDS | OrthoPediatrics | $204.73M | $52.80M |
SIBN | SI-BONE | $167.18M | $40.34M |
SRDX | Surmodics | $126.08M | $29.92M |
LUNG | Pulmonx | $83.79M | $20.39M |
NPCE | NeuroPace | $79.91M | $21.06M |
SGHT | Sight Sciences | $79.87M | $20.16M |
IRMD | IRadimed | $73.24M | $18.33M |
CVRX | CVRx | $51.29M | $13.37M |
PROF | Profound Medical | $10.68M | $1.90M |
OFIX | Orthofix Medical | - | $198.62M |